private-startup · medical-implant · communication-aac
Precision Neuroscience
At a glance
- Legal name
- Precision Neuroscience, Corp.
- Aliases
- —
- Type
- private-startup
- Focus areas
- medical-implant, communication-aac, prosthetic, rehabilitation, diagnostic
- Founded
- Defunct
- —
- Spinout of
- —
- HQ city
- New York
- HQ country
- US
- Employees
- —
- Flagship device
- precision-layer-7
- Product lines
- 1
- In-house manufacturing
- —
- Open source
- No
- GitHub org
- —
- Website
- precisionneuro.io
- Blog
- —
- Support
- —
Devices
People
Founders
Benjamin Rapoport
Co-Founder, Chief Science Officer
Michael Mager
Co-Founder, CEO
Demetrios Papageorgiou
Co-Founder
Mark Hettick
Co-Founder
Current leadership
Michael Mager
CEO
Benjamin Rapoport
Chief Science Officer
Milestones
Precision Neuroscience founded by Benjamin Rapoport, Michael Mager, Demetrios Papageorgiou, and Mark Hettick
FDA 510(k) clearance K242618 for the Layer 7-T Cortical Interface
Reputation
Co-founder Benjamin Rapoport was an original Neuralink co-founder; Precision is built around the explicitly opposite design philosophy — a non-penetrating, surface-conforming thin-film array intended to be reversibly placed and explanted without damaging cortex. Achieved a regulatory first by mapping its temporary device into the existing 21 CFR 882.1310 cortical electrode rule, securing 510(k) (Class II) instead of PMA.